Immatics N.V. (IMTX) director awarded 48,000 stock options at $9.09

Rhea-AI Filing Summary

Immatics N.V. director Peter Alan Chambre received a grant of stock options as part of his compensation. He was awarded 48,000 Stock Options (Right to Buy), each allowing purchase of one ordinary share at an exercise price of $9.09 per share.

The options vest 100% on the first anniversary of the grant date, June 16, 2026, and expire on June 15, 2036. Following this award, his reported holdings in this option grant total 48,000 derivative securities, with no shares bought or sold in the market in this filing.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Chambre Peter Alan

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	48,000	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 48,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 48,000 options Exercise price: $9.09 per share Total options after grant: 48,000 options +2 more

5 metrics

Options granted 48,000 options Stock Option (Right to Buy) grant to director

Exercise price $9.09 per share Conversion or exercise price for options

Total options after grant 48,000 options Total derivative securities following transaction

Vesting date June 16, 2026 100% vesting on first anniversary of grant

Expiration date June 15, 2036 Option expiration for this grant

Key Terms

Stock Option (Right to Buy), Ordinary Shares, Grant, award, or other acquisition, vest 100% on the first anniversary

4 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy) reported as derivative"

Ordinary Shares financial

"underlying_security_title: Ordinary Shares underlying the options"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

vest 100% on the first anniversary financial

"These Options vest 100% on the first anniversary of the grant date"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chambre Peter Alan

(Last) (First) (Middle)

PAUL-EHRLICH-STR. 15

(Street)

TUBINGEN 72076

(City) (State) (Zip)

GERMANY

(Country)

2. Issuer Name and Ticker or Trading Symbol
Immatics N.V. [ IMTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$9.09	06/16/2026		A		48,000		(1)	06/15/2036	Ordinary Shares	48,000	$0	48,000	D

Explanation of Responses:

1. These Options vest 100% on the first anniversary of the grant date, June 16, 2026.

	/s/ Edward Sturchio, attorney-in-fact for Peter Alan Chambre	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Immatics N.V. (IMTX) report in this Form 4?

Immatics N.V. reported that director Peter Alan Chambre received a grant of 48,000 stock options. These options are a compensation award, not an open-market purchase, and give him the right to buy ordinary shares at a fixed exercise price.

How many stock options did Peter Alan Chambre receive from Immatics N.V. (IMTX)?

Peter Alan Chambre received 48,000 Stock Options (Right to Buy) from Immatics N.V. This entire amount relates to a single option grant, and his total reported holdings in this specific grant are 48,000 derivative securities following the transaction.

What is the exercise price of the Immatics (IMTX) stock options granted to Peter Alan Chambre?

The stock options granted to Peter Alan Chambre have an exercise price of $9.09 per ordinary share. This means he can purchase each underlying Immatics N.V. share at $9.09 once the options vest and before they expire, subject to the plan’s terms.

When do Peter Alan Chambre’s Immatics (IMTX) stock options vest and expire?

The options vest 100% on June 16, 2026, the first anniversary of the grant date. They carry an expiration date of June 15, 2036, giving a long exercise window after vesting, provided other plan and service conditions are satisfied.

Did Peter Alan Chambre buy or sell any Immatics (IMTX) shares in the market?

No market purchases or sales were reported. The Form 4 shows a compensation-related grant of 48,000 stock options, coded as an acquisition (A) for grant or award, with no open-market buy or sell transactions in this filing.

What type of security underlies the Immatics (IMTX) options granted to Peter Alan Chambre?

The granted derivative securities are stock options linked to Immatics N.V. ordinary shares. Each of the 48,000 Stock Options (Right to Buy) is exercisable into one ordinary share at the $9.09 exercise price, once fully vested and prior to expiration.